Investor Database
2,209 investors tracked · Peer Scores computed from real founder reviews
We invest in early-stage startups with overlooked founders in humanity-focused sectors (primarily) Fintech, ClimateTech, and future of work/education. We are geographically agnostic. Pre-seed to series A.
We invest in practical AI applications to transform traditional digital business models, with a focus on B2C innovation that reshapes industries and enhances everyday life. We prioritise regions with untapped potential, including MENA, SEA, CEE, South Asia, and LATAM, while helping portfolio companies scale efficiently across key functions.
We invest at the MVP stage. Sector agnostic across capital-efficient industries.
We supports tech companies in the Kerala ecosystem.
We invest at pre-seed stage in the next generation of French entrepreneurs building tech companies in the US.
Colorado pre-seed fund investing in technical founders.
I invest in product-first companies that are looking to solve problems for their users.
We invest in Budding New Writers, Authors & Media Platforms.
Greek VC and accelerator supporting early-stage technology companies with capital and go-to-market support.
We invest in dual-use and deep tech startups, leveraging Starburst 4x markup and Fortune Global 500 partners.
We invest in B2C/ B2B2C Fintech, Insurtech and Digital Health startups who can benefit from NFP's distribution.
We invest in companies that market to or through physicians. Either physicians are the direct users of their products or the company needs to go through physicians to reach their customers like patients and hospitals. No specific vertical is preferred, we only care about who you market to.
Czech micro-VC investing in pre-seed and seed stage technology companies across Central and Eastern Europe.
We invest in outlier founders who are building compounding companies in Cybersecurity/Privacy/Data.
We invest in startups whose technologies have the potential to transform how people experience and achieve financial security, with four key strategic areas of focus: (1) Client experience and deepening engagement, (2) Dynamic underwriting and health data analytics, (3) Expanding distribution capabilities via “AdvisorTech,” and (4) Acquiring the next generation of clients.
We invest early in people building innovative and disruptive technologies for human health, the future-of-work, and the infrastructure that powers them both. Our broad investment thesis allows us to see a wide variety of companies, and pick those with the greatest potential for global impact, led by the best founders. We typically write $100K - $2M first checks into pre-Series A rounds, and are comfortable either leading or participating.
I invest in companies I believe are going to be great, much more of a "I know it when I see it" approach.
Abstract's second fund..
We invest in early and growth-stage startups. We're sector agnostic and have invested in over 160 companies across 17 different sectors and 7 countries.
We invest in entrepreneurs that are science-driven, deep experts in their startup's domain. We invest in areas around our subcritical thesis (https://skventures.substack.com/p/welcome-to-the-subcritical-society).
We invest in early stage life sciences companies with a focus in medical devices, digital health, heath tech, and drug discovery tools/software.
We invest in legacy industries — from construction and mining to energy, manufacturing, and logistics — sit at the edge of a transformation. A multi-trillion-dollar opportunity lies in reimagining these sectors through technology, sustainability, and bold innovation.
We invest in daring, internationally-ambitious, European digital entrepreneurs from Day One.
We invest in cutting-edge technologies that are reshaping markets and society, driven by industry-specific expertise. With a commitment to harnessing technology to improve society and lives, our specialized team identifies global trends propelling innovation and change, with deep knowledge in the sectors where we operate.
We invest in pre-seed to seed stage, blockchain, crypto, and web3 startups. We seek companies early, under $25M in valuation.
M25's third Midwest fund..
We invest and partner with determined entrepreneurs in their long-term quest of disrupting industries. Focus on blockchain and crypto startups.
Harlem Capital's third fund..
BoxGroup's third fund..
We invest in early-stage companies with focus on B2B SaaS models, but also look into other opportunities. The venture should not be older than 3 years (since incorporation) and have a distinct focus on the German market.
We invest in opportunities with near term milestones and clear technology advantages backed by strong teams and IP.
We invest in ambitious founders at idea stage
We invest in B2B software, SaaS, Construction, HealthTech, Sciences, Agritech, Robotics, Cybersecurity and many others. We invest in startups with sizeable market opportunities in the early stages, which include Seed, Series A, and Series B rounds.
We invest in technologies strategic to Hanwha Global, which includes sectors such as cleantech, energy, advanced materials, aerospace & defense, and enterprise AI. We are a stage-agnostic fund, though we tend to focus on post-product startups so that our business units have something tangible to use in their evaluation of strategic fit.
We invest in Programming biology (Synbio & TechBio), Food-Tech and Industry Decarbonization. We partner with entrepreneurs at the nucleus of their journey, investing at the Pre/Seed stage.
Argentine accelerator and seed VC investing in early-stage technology companies from Argentina and Latin America.
Charlotte-based seed fund investing in fintech and enterprise software in the Southeast.
We invest in early-stage companies across fitness, wellness, and health. We leverage the research from our weekly industry analysis to find opportunities and match that to idea stage to seed stage companies.
Early-stage VC linked to EPFL's deep tech ecosystem, investing in spinouts and startups from Swiss research institutions.
We invest in early-stage software startups B2C and B2B2C models (and B2B with short sale cycles) Tech-oriented companies, ideally proprietary, with a scalable product We like to be the first professional investor, coming in right after love money and business angels
We invest in early-stage consumer companies in search of remarkability.
We invest in construction, real estate, climate, and logistics.
I invest in early stage sports technology and gaming companies.
Techstars' Toronto accelerator program and seed fund.
We partner with early-stage software startups to apply expertise in software development, operations, marketing, sales and fundraising to help you launch and scale. The best technical partner to get software startups from 0-1.
We invest in founders catalyzing the next wave of web3/crypto adoption across defi, infrastructure, and web3 commerce.
Early-stage venture fund focusing on Turkish B2B SaaS and platform startups with global ambitions.
We invest in ambitious entrepreneurs building products across cloud, connectivity, data science and security with the potential to impact whole industries. That includes AI, machine learning, cloud computing, cybersecurity, HPC, IoT, quantum computing and wireless connectivity / networking to name a few areas.
Pre-seed fund investing in consumer companies..
We invest in B2B software companies revolutionizing legacy industries. We are sector-agnostic, with a geographic focus on Northeast US major markets. As entrepreneurs ourselves, we focus on GTM acceleration, operational execution, and capital strategy. With our founder-focused DNA, concentrated portfolio, and disciplined investment process, we help entrepreneurs build category-leading companies.